Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease.
about
GDNF is not required for catecholaminergic neuron survival in vivoSensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model.A translational approach to capture gait signatures of neurological disorders in mice and humans.Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.Moving stem cells to the clinic: potential and limitations for brain repairLoss of Striatonigral GABAergic Presynaptic Inhibition Enables Motor Sensitization in Parkinsonian Mice.Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.Electroacupuncture Produces the Sustained Motor Improvement in 6-Hydroxydopamine-Lesioned Mice.Glycine transporter-1 inhibition promotes striatal axon sprouting via NMDA receptors in dopamine neuronsThe significance of neuronal lateralisation in Parkinson's disease.Oxidative stress in genetic mouse models of Parkinson's disease.Heterotopic Mucosal Grafting Enables the Delivery of Therapeutic Neuropeptides Across the Blood Brain Barrier.Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervationEarly Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease.Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease.Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving AnimalsPACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2.Choroid plexus-cerebrospinal fluid route for monocyte-derived macrophages after stroke.Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease.Overview of mouse models of Parkinson's disease.Comparison of 6-hydroxydopamine lesions of the substantia nigra and the medial forebrain bundle on a lateralised choice reaction time task in mice.Behavioural recovery on simple and complex tasks by means of cell replacement therapy in unilateral 6-hydroxydopamine-lesioned mice.CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.Neuroprotective Effects of Sulphated Agaran from Marine Alga Gracilaria cornea in Rat 6-Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations.α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain.Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP.Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA Rat Model of Parkinson's Disease.Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson's disease.Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with RatsRepeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior
P2860
Q27312615-88A0478D-C3F4-4C2A-A991-B8C74B39399FQ30512976-26D83D6E-C196-49CD-A6C7-48A3D26A8EA5Q30829270-8E1B91D3-23AB-4108-9027-0CAE2FF3E4ABQ30855500-7B24FEB3-D713-4E06-952A-9AB2C57245A5Q33819387-8AF59F29-D752-4A38-89F2-3BEB36CB94EBQ34470920-11342395-A61B-4CC8-A6A4-C329C4DC3909Q34492283-C2CB1564-D525-42BF-9163-CC9C2CA2B3C8Q35619338-BF3C45F8-58D1-49D1-9A94-C620208B144AQ35828317-9EC07A3F-070A-4C58-96DD-77A0D18C3C2BQ35857994-DA4D4213-C205-427E-B711-D02C6B7253C8Q36610244-55AB82A5-156F-4D07-90F8-A5C0C06FDE45Q37231520-89E4873E-FEEC-43D6-97A2-8F96A1788D37Q37988384-E12A662F-A101-4427-A1F5-F982237D61EAQ38029327-7845C4E9-84F1-484E-89F7-1C1CCC16F889Q38836658-DFB03F0C-45A5-4606-86A9-4E8C30F022AFQ39018573-E7977202-3202-4046-8760-DB9AE16E0A0CQ39075710-EB69CD48-DEC4-4132-82C4-D98F84BFC444Q39284027-AE7E4D41-A810-4160-A18C-DEC665F7184BQ39440585-BB0792E3-807B-4F14-9EA1-C74CB1CEC689Q41025619-BB3715A7-F1E6-414D-BFB5-7EF419674553Q41769727-F6D1385F-C46C-4DB3-8784-B154739BFB00Q41834713-E3762FFA-7212-4E71-AD0A-5253E5AECA5AQ41904397-E6808A5E-42C4-411A-8DD4-2FA644610E54Q42473489-2423AB1D-9379-4F58-ADDE-DA49F78E36FAQ45053410-4A38D44A-03A0-4F8E-82F5-5901D5B9223AQ45363661-34DBB6E5-A961-454C-977D-28E84D1A7DBFQ47920457-EF92A58E-CABC-43E6-B7E4-AC3E718777B2Q48152730-D10EC934-22F3-45B6-9EFB-0885CC0D64DBQ48521515-7902F3EA-BA72-4B24-B596-9A12D58D15B2Q48561683-6188839C-9A5B-4CC8-B585-93AD77B49E3AQ48572358-22F79773-8E79-477A-A7BA-5FEA9279273FQ49499665-8D10172A-1E43-4BC8-A7BD-285F3CBDAAE3Q52645963-D5CD66B3-AE76-475B-A396-05AC8C138315Q55346192-BAB96944-F01B-4A23-820C-1ADFFB14C4C4Q57515344-A45D281B-BE1B-4D69-B388-5B5C33505DE4Q58749782-107D4469-8763-49CE-9044-06E344B0297E
P2860
Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterisation of behavioura ...... model of Parkinson's disease.
@ast
Characterisation of behavioura ...... model of Parkinson's disease.
@en
type
label
Characterisation of behavioura ...... model of Parkinson's disease.
@ast
Characterisation of behavioura ...... model of Parkinson's disease.
@en
prefLabel
Characterisation of behavioura ...... model of Parkinson's disease.
@ast
Characterisation of behavioura ...... model of Parkinson's disease.
@en
P1476
Characterisation of behavioura ...... model of Parkinson's disease.
@en
P2093
Bengt Mattsson
Peter Draxler
P304
P356
10.1111/J.1460-9568.2010.07265.X
P407
P577
2010-06-01T00:00:00Z